Publications 1996

1. Binnerts ME, van Kooyk Y, Edwards CP, Champe M, Presta L, Bodary SC, Figdor CG, Berman PW. Antibodies that selectively inhibit leukocyte function-associated antigen 1 binding to intercellular adhesion molecule-3 recognize a unique epitope within the CD11a I domain. J Biol Chem, 1996. 271(17): 9962-8.

2. van de Stolpe A, Jacobs N, Hage WJ, Tertoolen L, van Kooyk Y, Novakova IR, de Witte T. Fibrinogen binding to ICAM-1 on EA.hy 926 endothelial cells is dependent on an intact cytoskeleton. Thromb Haemost, 1996. 75(1): 182-9.

3. Buysmann S, Bemelman FJ, Schellekens PT, van Kooyk Y, Figdor CG, ten Berge IJ. Activation and increased expression of adhesion molecules on peripheral blood lymphocytes is a mechanism for the immediate lymphocytopenia after administration of OKT3. Blood, 1996. 87(1): 404-11.

4. van Kooyk Y, Binnerts ME, Edwards CP, Champe M, Berman PW, Figdor CG, Bodary SC. Critical amino acids in the lymphocyte function-associated antigen-1 I domain mediate intercellular adhesion molecule 3 binding and immune function. J Exp Med, 1996. 183(3): 1247-52.

5. Lub M, van Kooyk Y, Figdor CG. Competition between lymphocyte function-associated antigen 1 (CD11a/CD18) and Mac-1 (CD11b/CD18) for binding to intercellular adhesion molecule-1 (CD54). J Leukoc Biol, 1996. 59(5): 648-55.

6. Adema GJ, Bakker AB, de Boer AJ, Hohenstein P, Figdor CG. pMel17 is recognised by monoclonal antibodies NKI-beteb, HMB-45 and HMB-50 and by anti-melanoma CTL. Br J Cancer, 1996. 73(9): 1044-8.

7. Torensma R, Raymakers RA, van Kooyk Y, Figdor CG. Induction of LFA-1 on pluripotent CD34+ bone marrow cells does not affect lineage commitment. Blood, 1996. 87(10): 4120-8.

8. Marland G, Bakker AB, Adema GJ, Figdor CG. Dendritic cells in immune response induction. Stem Cells, 1996. 14(5): 501-7.